About The DPC Education Center

The Center is dedicated to improving kidney patients’ quality of life and reducing the occurrence of ESRD through education and by developing awareness of dialysis and kidney disease issues, improving the partnership between patients and caregivers, and developing favorable public policy solutions.

 

Generic Version of Transplant Drug Found to Perform as well as Brand

A recent study conducted by the University of Cincinnati found that patient outcomes were almost identical for generic and brand-name versions of tacrolimus, a drug used post-transplant to reduce the risk of organ rejection. With more affordable generics now on the market, the study took a closer look at the outcomes of what have often been referred to as narrow therapeutic index medications.